Literature DB >> 7441647

Muramyl dipeptide stimulation of particle clearance in several animal species.

R V Waters, R W Ferraresi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7441647

Source DB:  PubMed          Journal:  J Reticuloendothel Soc        ISSN: 0033-6890


× No keyword cloud information.
  13 in total

1.  Liposomal muramyl dipeptide therapy of experimental M5076 liver metastases in mice.

Authors:  N C Phillips; M S Tsao
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Protective effect of a muramyl dipeptide analog encapsulated in or mixed with liposomes against Candida albicans infection.

Authors:  E B Fraser-Smith; D A Eppstein; M A Larsen; T R Matthews
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

3.  Anti-infectious activity of liposomal muramyl dipeptides in immunodeficient CBA/N mice.

Authors:  N C Phillips; L Chedid
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

4.  Protective effect of muramyl dipeptide analogs against infections of Pseudomonas aeruginosa or Candida albicans in mice.

Authors:  E B Fraser-Smith; T R Matthews
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

5.  Prevention of oncogenic viral infections in mice with CGP 11637, a synthetic muramyl dipeptide analog.

Authors:  H F Acevedo; R B Raikow; H O Acevedo; T F Delgado; M Pardo
Journal:  Antimicrob Agents Chemother       Date:  1985-11       Impact factor: 5.191

6.  Modulation of myelopoiesis in vivo by synthetic adjuvant-active muramyl peptides: induction of colony-stimulating activity and stimulation of stem cell proliferation.

Authors:  A Galelli; L Chedid
Journal:  Infect Immun       Date:  1983-12       Impact factor: 3.441

7.  Synergistic effect of glucantime and a liposome-encapsulated muramyl dipeptide analog in therapy of experimental visceral leishmaniasis.

Authors:  L E Adinolfi; P F Bonventre; M Vander Pas; D A Eppstein
Journal:  Infect Immun       Date:  1985-05       Impact factor: 3.441

Review 8.  Kupffer cells and liver metastasis. Optimization and limitation of activation of tumoricidal activity.

Authors:  N C Phillips
Journal:  Cancer Metastasis Rev       Date:  1989-12       Impact factor: 9.264

9.  Correlation between in vivo anti-Pseudomonas and anti-Candida activities and clearance of carbon by the reticuloendothelial system for various muramyl dipeptide analogs, using normal and immunosuppressed mice.

Authors:  E B Fraser-Smith; R V Waters; T R Matthews
Journal:  Infect Immun       Date:  1982-01       Impact factor: 3.441

10.  Biological activity of a new synthetic muramyl peptide adjuvant devoid of pyrogenicity.

Authors:  L A Chedid; M A Parant; F M Audibert; G J Riveau; F J Parant; E Lederer; J P Choay; P L Lefrancier
Journal:  Infect Immun       Date:  1982-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.